Literature DB >> 23270629

Molecular signature of human amniotic fluid stem cells during fetal development.

Dafni Moschidou1, Katharina Drews, Ayad Eddaoudi, James Adjaye, Paolo De Coppi, Pascale V Guillot.   

Abstract

Mid-gestation c-KIT(+) amniotic fluid stem cells (AFSC) have an intermediate phenotype between embryonic and adult stem cells and are easy to reprogram to pluripotency. We previously showed that 1st trimester AFSC can be reprogrammed to functional pluripotency in a transgene-free approach. Despite both parental populations sharing a common phenotype, expressing CD29, CD44, CD73, CD90, CD105, SSEA4 and OCT4, 2nd trimester AFSC, contrary to 1st trimester cells, do not express NANOG, SSEA3, TRA-1-60 and TRA-1-81, and have slower growth kinetics. Here, we used the Illumina Beadstudio microarray platform to analyse the transcriptome of 1st and 2nd trimester AFSC and show a unique 1st trimester AFSC-specific gene expression signature consisting of 366 genes and a larger set of 603 genes common with hESC compared to 496 genes overlapping between 2nd trimester AFSC and hESC. We conclude that both populations are related but distinct to each other as well as to hESC.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23270629     DOI: 10.2174/1574888x11308010009

Source DB:  PubMed          Journal:  Curr Stem Cell Res Ther        ISSN: 1574-888X            Impact factor:   3.828


  17 in total

Review 1.  NANOG expression in human development and cancerogenesis.

Authors:  Gašper Grubelnik; Emanuela Boštjančič; Ana Pavlič; Marina Kos; Nina Zidar
Journal:  Exp Biol Med (Maywood)       Date:  2020-02-10

2.  Culture of mouse amniotic fluid-derived cells on irradiated STO feeders results in the generation of primitive endoderm cell lines capable of self-renewal in vitro.

Authors:  Aleksandar M Babic; Sunyoung Jang; Eugenia Nicolov; Horatiu Voicu; Chance J Luckey
Journal:  Cells Tissues Organs       Date:  2013-09-21       Impact factor: 2.481

3.  Sox2 suppression by miR-21 governs human mesenchymal stem cell properties.

Authors:  Ourania Trohatou; Dimitra Zagoura; Vasiliki Bitsika; Kalliopi I Pappa; Aristidis Antsaklis; Nicholas P Anagnou; Maria G Roubelakis
Journal:  Stem Cells Transl Med       Date:  2013-12-04       Impact factor: 6.940

4.  Immune regulatory properties of CD117(pos) amniotic fluid stem cells vary according to gestational age.

Authors:  Mariano Di Trapani; Giulio Bassi; Emanuela Fontana; Luca Giacomello; Michela Pozzobon; Pascale V Guillot; Paolo De Coppi; Mauro Krampera
Journal:  Stem Cells Dev       Date:  2015-01-01       Impact factor: 3.272

5.  Human Amniotic Fluid Mesenchymal Stem Cells from Second- and Third-Trimester Amniocentesis: Differentiation Potential, Molecular Signature, and Proteome Analysis.

Authors:  Jurate Savickiene; Grazina Treigyte; Sandra Baronaite; Giedre Valiuliene; Algirdas Kaupinis; Mindaugas Valius; Audrone Arlauskiene; Ruta Navakauskiene
Journal:  Stem Cells Int       Date:  2015-08-17       Impact factor: 5.443

6.  Counteracting bone fragility with human amniotic mesenchymal stem cells.

Authors:  Anna M Ranzoni; Michelangelo Corcelli; Kwan-Leong Hau; Jemma G Kerns; Maximilien Vanleene; Sandra Shefelbine; Gemma N Jones; Dafni Moschidou; Benan Dala-Ali; Allen E Goodship; Paolo De Coppi; Timothy R Arnett; Pascale V Guillot
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

7.  Neuroprotection of the hypoxic-ischemic mouse brain by human CD117+CD90+CD105+ amniotic fluid stem cells.

Authors:  Michelangelo Corcelli; Kate Hawkins; Filipa Vlahova; Avina Hunjan; Kate Dowding; Paolo De Coppi; Anna L David; Donald Peebles; Pierre Gressens; Henrik Hagberg; Mariya Hristova; Pascale V Guillot
Journal:  Sci Rep       Date:  2018-02-05       Impact factor: 4.379

8.  Human Amniocytes Are Receptive to Chemically Induced Reprogramming to Pluripotency.

Authors:  Kate E Hawkins; Dafni Moschidou; Danilo Faccenda; Wasco Wruck; Alex Martin-Trujillo; Kwan-Leong Hau; Anna Maria Ranzoni; Veronica Sanchez-Freire; Fabio Tommasini; Simon Eaton; Paolo De Coppi; David Monk; Michelangelo Campanella; Adrian J Thrasher; James Adjaye; Pascale V Guillot
Journal:  Mol Ther       Date:  2017-02-01       Impact factor: 11.454

Review 9.  Engineering muscle tissue for the fetus: getting ready for a strong life.

Authors:  George J Christ; Mevan L Siriwardane; Paolo de Coppi
Journal:  Front Pharmacol       Date:  2015-04-10       Impact factor: 5.810

Review 10.  Amniotic Fluid Stem Cells: A Novel Source for Modeling of Human Genetic Diseases.

Authors:  Ivana Antonucci; Martina Provenzano; Melissa Rodrigues; Andrea Pantalone; Vincenzo Salini; Patrizia Ballerini; Cesar V Borlongan; Liborio Stuppia
Journal:  Int J Mol Sci       Date:  2016-04-22       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.